期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

利妥昔单抗联合CHOPE方案治疗原发性纵隔(胸腺)大B细胞淋巴瘤一例并文献复习 被引量：1

原文传递
导出
摘要 目的探讨利妥昔单抗(商品名:美罗华)联合CHOPE方案治疗原发性纵隔(胸腺)大B细胞淋巴瘤(PMBL)的治疗方法。方法报道1例PMBL的临床资料,探讨美罗华联合CHOPE方案治疗结果,并复习相关文献。结果患者确诊后给予CHOPE方案治疗9疗程,2￣7疗程时与美罗华联合治疗6次。治疗结束后达完全缓解。随访至今,完全缓解16个月。结论本例患者采用美罗华联合CHOPE方案治疗PMBL,治疗效果肯定,毒副作用轻微,对经济条件许可的患者,可考虑作为一线治疗方案。
作者 甘戈 李桂芳
机构地区 解放军第四五四医院血液肿瘤科
出处 《白血病．淋巴瘤》 CAS 2006年第6期461-462,共2页 Journal of Leukemia & Lymphoma
关键词 美罗华 CHOICE方案 纵隔(胸腺)大B细胞淋巴瘤
分类号 R734.5 [医药卫生—肿瘤]
  • 相关文献

参考文献5

  • 1李梦涛,段云,陈书长,沈悌.原发纵隔大B细胞淋巴瘤四例临床分析[J].中华血液学杂志,2002,23(10):552-554. 被引量：2
  • 2纪洪,张文燕,刘卫平,李甘地,李雷.纵隔(胸腺)大B细胞淋巴瘤三例[J].中华病理学杂志,2005,34(5):315-317. 被引量：6
  • 3Zinzani P L,Martelli M,Bendandi M,et al.Primary mediastinal large B-cell lymphoma with sclerosis:a clinical study of 89 patients treatedwith MACOP-B chemothrapy and radiation therapy[J].Haematologica,2001,86(2):187-191.
  • 4Vose J M,Link B K,GrosSbaRd M L,et al.Phase Ⅱ study of rituximab in combination with chop chemothrapy in patients with previously untreated,aggressive non-Hodgkin lymphoma[J].J Clin Oncol,2001,19(2):389-397.
  • 5Coiffier B,Lepage E,Briere J,et al.CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma[J].N Engl J Med,2002,346(4):235-242.

二级参考文献14

  • 1A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma.The Non-Hodgkin's Lymphoma Classification Project. Blood,1997, 89: 3909-3918.
  • 2Cazals-Hatem D, Lepage E, Brice P, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphoma, a GELA study. Am J Surg Pathol, 1996, 20: 877-888.
  • 3Perrone T, Frizzzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol, 1986,10: 176-191.
  • 4Davis RE, Dorfman KF, Warnke RA. Primary large-cell lymphoma of the thymus: a diffuse B-cell neoplasm presenting as primary mediastinal lymphoma. Hum Pathol, 1990, 21:1262-1268.
  • 5Zinzani PL, Martelli M, Magagnoli M, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)gallium scan in 50 patients. Blood,1999, 94: 3289-3293 .
  • 6Lamarre L, Jacobson JO, Aisenberg AC, et al. Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol, 1989, 13: 730-739.
  • 7van Besien KV, Kelta M, Bahaguna P. Primary mediastinal B-cell lymphoma:a review of pathology and management. J Clin Oncol, 2001, 19: 1855-1864.
  • 8Pileri SA, Gaidano G, Zinzani PL, et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol, 2003,162:243-253.
  • 9Yonetani N, Kurata M, Nishikori M, et al. Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease. Int J Hematol, 2001, 74: 178-185.
  • 10Joos S, Otano-Joos MI, Ziegler S, et al. Primary mediastina (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood,1996, 87: 1571-1578.

共引文献6

同被引文献9

引证文献1

二级引证文献2

白血病．淋巴瘤
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部